EPI-326: clinical trials recruiting now

Fewer than 3 recruiting trials found.

Recruiting trials

Conditions studied

US states with sites

Countries

Phase breakdown

Phase 1 1

Condition	Trials
EGFR	1
Epidermal Growth Factor	1
Epidermal Growth Factor Receptor	1
Epidermal Growth Factor Receptor Gene Mutation	1
HNSCC	1
Head and Neck	1
Head and Neck Cancer	1
Head and Neck Cancers	1
Head and Neck Squamous Cell Cancer	1
Head and Neck Squamous Cell Carcinoma	1
Head and Neck Squamous Cell Carcinoma HNSCC	1
Lung cancer	1
NSCLC (Non-small Cell Lung Cancer)	1
Non Small Cell	1
Non Small Cell Lung	1

A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC
NCT07462377 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 6 locations

1 recruiting trial across 15 conditions.

No. For the full record, search ClinicalTrials.gov.